Hind El Azzazi: Successful Defense of My Medical Doctorate on Antiphospholipid Syndrome in Men
Hind El Azzazi, Medical Intern at the Ministry of Health and Social Protection in Morocco, shared a post on LinkedIn:
“03.18.2026, officially EL Azzazi Hina, M.D.
I am honored to announce the successful defense of my medical doctorate thesis entitled: ‘Clinical, Biological, and Prognostic Features of Antiphospholipid Syndrome in Men: A Case Series and Narrative Review of the Literature’
This thesis represents the culmination of years of dedication and marks a pivotal moment in my medical journey.
Antiphospholipid syndrome (APS) remains a fascinating condition due to its complexity and multisystemic nature. Exploring its unique characteristics in the male population has deepened my understanding of thrombotic mechanisms and the intricate interplay between autoimmunity and cardiovascular risk factors, particularly the relationship with atherosclerosis in elderly patients, which sparked engaging discussions during the defense.
Working on this thesis has ignited a genuine passion for autoimmune diseases. The complexity of these conditions, their diagnostic challenges, and the evolving therapeutic landscape have captivated my interest and inspired me to explore it further in my future medical career.
I would like to express my deepest gratitude to:
Pr. Youssef Sekkach, my thesis director, for his exceptional mentorship, scientific rigor, and unwavering trust throughout this journey
Dr. Oumama Jamal, for her invaluable guidance, constant availability, and tremendous support every step of the way
The distinguished jury members for their insightful feedback and stimulating discussions: Hicham Harmouche, Ahmed Bourezza, Najat Mouine, and Naoual EL Omri
My dear parents and family, whose unconditional love, sacrifices, and endless encouragement have been the foundation of everything I have achieved. This accomplishment is as much yours as it is mine. Thank you for believing in me every single day
This milestone marks not only the completion of a long scientific endeavor but also the beginning of a new chapter, one driven by curiosity, humility, and a renewed commitment to medicine and research.
To all those who accompanied me on this journey, friends, mentors, and family alike, your presence, patience, and unwavering belief have meant everything.
Thank you, from the bottom of my heart!”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation
-
Aug 21, 2026, 09:07Sujal Lohana: Building a Better Blood Donor–Seeker App
-
Aug 21, 2026, 08:55Robert Sidonio: Connecting Experts in Bleeding and Clotting Disorders